Arcus Biosciences, Inc. Increase (Decrease) in Accounts Payable
Arcus Biosciences, Inc. (RCUS) reported Increase (Decrease) in Accounts Payable of -$8.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05
- Arcus Biosciences, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$5.00M, a 162.50% decline year-over-year.
- Arcus Biosciences, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$3.00M, a 200.00% decline year-over-year.
- Arcus Biosciences, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Arcus Biosciences, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $13.00M.
- Arcus Biosciences, Inc. increase (decrease) in accounts payable for fiscal 2025 was $24.00M, a 700.00% increase from fiscal 2024.
- Arcus Biosciences, Inc. increase (decrease) in accounts payable for fiscal 2024 was $3.00M.
- Arcus Biosciences, Inc. increase (decrease) in accounts payable for fiscal 2023 was -$1.00M, a 112.50% decline from fiscal 2022.
- Arcus Biosciences, Inc. increase (decrease) in accounts payable for fiscal 2022 was $8.00M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$8.00M 10-Q · filed 2026-08-05 | -$8.00M derived: sum of 3 quarters · filed 2026-08-05 | $5.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$3.00M 10-Q · filed 2026-05-05 | -$3.00M derived: sum of 2 quarters · filed 2026-05-05 | $10.00M derived: sum of 3 quarters · filed 2026-05-05 | $18.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $13.00M derived: sum of 2 quarters · filed 2026-02-25 | $21.00M derived: sum of 3 quarters · filed 2026-08-05 | $24.00M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $13.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $21.00M derived: sum of 2 quarters · filed 2026-08-05 | $24.00M 10-Q · filed 2025-10-28 | $29.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $11.00M 10-Q · filed 2026-08-05 | $16.00M derived: sum of 3 quarters · filed 2026-08-05 | $15.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $3.00M 10-Q · filed 2026-05-05 | $8.00M derived: sum of 2 quarters · filed 2026-05-05 | $7.00M derived: sum of 3 quarters · filed 2026-05-05 | $7.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.00M derived: sum of 2 quarters · filed 2026-02-25 | $4.00M derived: sum of 3 quarters · filed 2026-02-25 | $3.00M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$1.00M derived: sum of 2 quarters · filed 2025-10-28 | -$2.00M 10-Q · filed 2025-10-28 | $0.00 derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$1.00M 10-Q · filed 2025-08-06 | $1.00M derived: sum of 3 quarters · filed 2026-02-25 | $7.00M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | -$1.00M 10-Q · filed 2025-05-06 | $1.00M derived: sum of 2 quarters · filed 2026-02-25 | $7.00M derived: sum of 3 quarters · filed 2026-02-25 | -$12.00M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $8.00M derived: sum of 2 quarters · filed 2026-02-25 | -$11.00M derived: sum of 3 quarters · filed 2026-02-25 | -$1.00M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$13.00M derived: sum of 2 quarters · filed 2024-11-06 | -$3.00M 10-Q · filed 2024-11-06 | $5.00M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | -$19.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$9.00M 10-Q · filed 2024-08-08 | -$1.00M derived: sum of 3 quarters · filed 2025-02-25 | -$13.00M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $10.00M 10-Q · filed 2024-05-08 | $18.00M derived: sum of 2 quarters · filed 2025-02-25 | $6.00M derived: sum of 3 quarters · filed 2025-02-25 | $10.00M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$4.00M derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $8.00M 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | -$12.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$8.00M derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | -$54.00K 10-Q · filed 2022-11-02 | $424.00K derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $12.00M 10-Q · filed 2023-08-07 | $12.10M 10-Q · filed 2022-08-03 | $12.42M derived: sum of 3 quarters · filed 2024-02-21 | $10.57M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-03-31 | $8.00M 10-Q · filed 2023-05-09 | $8.14M 10-Q · filed 2022-05-09 | $8.42M derived: sum of 2 quarters · filed 2024-02-21 | $6.57M derived: sum of 3 quarters · filed 2024-02-21 | -$4.72M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | $424.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$1.43M derived: sum of 2 quarters · filed 2024-02-21 | -$12.72M derived: sum of 3 quarters · filed 2024-02-21 | -$5.00M 10-K · filed 2024-02-21 | -$4.77M 10-K · filed 2022-02-23 | |||
| 2021-09-30 | -$1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$13.15M derived: sum of 2 quarters · filed 2022-11-02 | -$5.42M 10-Q · filed 2022-11-02 | $411.00K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | -$11.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$3.57M 10-Q · filed 2022-08-03 | $2.27M derived: sum of 3 quarters · filed 2023-02-28 | -$1.24M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $7.72M 10-Q · filed 2022-05-09 | $13.56M derived: sum of 2 quarters · filed 2023-02-28 | $10.05M derived: sum of 3 quarters · filed 2023-02-28 | $19.06M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $5.83M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $2.33M derived: sum of 2 quarters · filed 2023-02-28 | $11.34M derived: sum of 3 quarters · filed 2023-02-28 | $9.00M 10-K · filed 2023-02-28 | $9.27M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | -$3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $5.51M derived: sum of 2 quarters · filed 2021-11-08 | $3.17M 10-Q · filed 2021-11-08 | $4.99M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | $9.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $6.67M 10-Q · filed 2021-08-05 | $8.49M derived: sum of 3 quarters · filed 2022-02-23 | $8.96M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | -$2.34M 10-Q · filed 2021-05-05 | -$522.00K derived: sum of 2 quarters · filed 2022-02-23 | -$50.00K derived: sum of 3 quarters · filed 2022-02-23 | -$99.00K derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $2.29M derived: sum of 2 quarters · filed 2022-02-23 | $2.24M derived: sum of 3 quarters · filed 2022-02-23 | $1.73M 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | $472.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $423.00K derived: sum of 2 quarters · filed 2020-11-05 | -$94.00K 10-Q · filed 2020-11-05 | $866.00K derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$566.00K 10-Q · filed 2020-08-06 | $394.00K derived: sum of 3 quarters · filed 2021-02-25 | -$1.98M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | -$517.00K 10-Q · filed 2020-05-05 | $443.00K derived: sum of 2 quarters · filed 2021-02-25 | -$1.93M derived: sum of 3 quarters · filed 2021-02-25 | -$280.00K derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $960.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$1.42M derived: sum of 2 quarters · filed 2021-02-25 | $237.00K derived: sum of 3 quarters · filed 2021-02-25 | -$69.00K 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$723.00K derived: sum of 2 quarters · filed 2019-11-05 | -$1.03M 10-Q · filed 2019-11-05 | $1.01M derived: sum of 4 quarters · filed 2019-11-05 | ||||
| 2018-06-30 | $1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $1.35M 10-Q · filed 2019-08-06 | $3.39M derived: sum of 3 quarters · filed 2019-08-06 | $2.69M derived: sum of 4 quarters · filed 2019-08-06 | ||||
| 2018-03-31 | -$306.00K 10-Q · filed 2019-05-02 | $1.73M derived: sum of 2 quarters · filed 2019-05-02 | $1.04M derived: sum of 3 quarters · filed 2019-05-02 | $2.12M derived: sum of 4 quarters · filed 2019-05-02 | ||||
| 2017-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05 | $1.34M derived: sum of 2 quarters · filed 2019-03-05 | $2.42M derived: sum of 3 quarters · filed 2019-03-05 | -$267.00K 10-K · filed 2019-03-05 | ||||
| 2017-09-30 | -$696.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $386.00K derived: sum of 2 quarters · filed 2018-11-08 | -$2.31M 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$1.61M 10-Q · filed 2018-08-06 | ||||||
| 2017-03-31 | -$2.69M 10-Q · filed 2018-05-09 | |||||||
| 2016-12-31 | $3.57M 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |